FindTrial
Sign In

Clinicopathological and prognostic features of limited-stage small cell carcinoma of the esophagus: a retrospective clinical study

Clinicopathological and prognostic features of limited-stage small cell carcinoma of the esophagus: a retrospective clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091485
Enrollment
Unknown
Registered
2024-10-29
Start date
2023-03-15
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

limited-stage small cell carcinoma of the esophagus

Interventions

Observation group:None

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The patients with limited-stage small cell carcinoma of the esophagus who received therapy in our hospital between 2010-2022.

Exclusion criteria

Exclusion criteria: Loss of patients information or loss follow-up.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Progressive free survival time;Remote transfer status;Lymph node metastasis status;—

Countries

China

Contacts

Public ContactJun Peng

Sichuan Cancer Hospital

drpengj@gmail.com+86 136 8836 2989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026